Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
59.30
-0.70 (-1.17%)
Sep 21, 2026, 1:32 PM EDT - Market open
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $194.15 million as of September 21, 2026. Its market cap has increased by 128.41% in one year.
Market Cap
194.15M
Enterprise Value
146.99M
1-Year Change
128.41%
Ranking
Category
Stock Price
$59.30
ChartMarket Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has decreased from $228.30M to $194.15M, a decrease of -14.96%. That is a compound annual growth rate of -1.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 194.15M | 65.37% |
| Dec 31, 2025 | 117.40M | 353.28% |
| Dec 31, 2024 | 25.90M | -15.91% |
| Dec 29, 2023 | 30.80M | -70.81% |
| Dec 30, 2022 | 105.50M | -38.34% |
| Dec 31, 2021 | 171.10M | -24.02% |
| Dec 31, 2020 | 225.20M | -35.58% |
| Dec 31, 2019 | 349.60M | 206.94% |
| Dec 31, 2018 | 113.90M | -50.11% |
| Feb 1, 2018 | 228.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veraxa Biotech AG | 206.46M |
| Nkarta | 202.70M |
| PepGen | 197.39M |
| Satellos Bioscience | 197.34M |
| Oramed Pharmaceuticals | 197.17M |
| Surrozen | 194.52M |
| Alpha Cognition | 192.30M |
| Acumen Pharmaceuticals | 191.64M |